Navigation Links
Fourth IMPAKT Breast Cancer Conference
Date:4/25/2012

but many
  • Mucin-1 protein and mRNA expression in breast cancer patients treated with neoadjuvant chemotherapy
  • Independent blinded validation of the genomic index of Sensitivity to Endocrine Therapy (SET)
  • The role of AP-1 in endocrine-resistant breast cancer
  • Advances in breast cancer research help choose the right treatment for the right patient
  • Gene modules and pathological complete response to neoadjuvant chemotherapy in breast cancer: a pooled analysis
  • Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically-defined Luminal A breast cancer
  • Translational studies within the TAMRAD randomized GINECO trial: Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer
  • Breast cancer in young women is a biologically unique disease that requires customized management strategies

    Highlights on:

    • Challenges, clinical perspectives and implications for biomarker and drug development
    • Making personalized medicine a reality for breast cancer patients: how to speed up the path for reimbursement
    • Intratumor heterogeneity: a challenge for personalized medicine? Can next generation sequencing help solve the problem?
    • Towards a further segmentation of triple negative breast cancer?
    • Can gene signatures become a standard procedure for daily practice? What's new to predict outcome and drug sensitivity?

    Press conference

    Thursday, 3 May 2012, 11:00-12:00 (CEST)

    Hosts:

    Martine Piccart, Jules Bordet Institute, Head of Chemotherapy Unit, Brussels, Belgium, IMPAKT Co-Founder

    Fabrice Andr, Institut de Cancrologie Gustave Roussy, Breast cancer Unit, Department of Medical Oncology, Villejuif, France, IMPAKT2012 Scientific Chair

    Sherene Loi, Institute Jules Bordet, Breast International Group (BIG), Brussels, Belgium, IMPAKT2012 Executive Chair

    Th
    '/>"/>


  • Contact: Vanessa Pavinato
    media@esmo.org
    European Society for Medical Oncology
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008
    2. BIO-key(R) Announces Fourth Quarter and 2008 Year-End Earnings Release and Conference Call Schedule
    3. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
    4. BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008
    5. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
    6. BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability
    7. MiMedx Group, Inc. Announces Release Date for 2010 Fourth Quarter and Full Year Results
    8. AACR hosts Fourth Annual Science of Cancer Health Disparities Conference
    9. Modern genetics answers age-old question on Garrods fourth inborn error of metabolism
    10. Aware, Inc. Reports Fourth Quarter and 2011 Financial Results
    11. IMPAKT -- Breast cancer conference highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
    (Date:12/10/2014)... Dec. 9, 2014  Wake Forest Baptist Medical Center today ... its School of Medicine. Funding for this $50 million ... that will be publicly launched next summer. ... the former 60 series R.J. Reynolds Tobacco Company complex, ... will begin immediately with plans to be ready to ...
    (Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
    Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
    ... wife, Elizabeth, have made a $5 million gift to ... Adult Stem Cell Research at the University of Notre ... endowed professorships in adult and all forms of non-embryonic ... the field of stem cell research and enhance the ...
    ... who have each been assigned a wetland plant or animal ... their assigned plant or animal interacts with in some way. ... describes an event that affects one "organism." That "organism" tugs ... tug on their strings in turn. The lesson is ...
    ... from Ludwig-Maximilians-Universitt (LMU) in Munich have identified an enzyme ... essential for bacterial pathogenicity. Because it shows no similarity ... target for development of novel antimicrobial drugs. ... that these strains become pathogenic only when an enzyme ...
    Cached Biology News:Notre Dame establishes professorships in adult stem cell research 2Notre Dame establishes professorships in adult stem cell research 3Foundational concept of ecology tested by experiment 2Foundational concept of ecology tested by experiment 3Foundational concept of ecology tested by experiment 4
    (Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
    (Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
    (Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
    (Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
    Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
    ... Jan. 28 Kendle (Nasdaq: KNDL ), ... Chairman and Chief Executive Officer Candace Kendle, PharmD,will ... conference,will be held at the Langham Hotel in ... Wednesday, Jan. 30 at 1:30 p.m. Eastern Time., ...
    ... Inc., a clinical,stage biopharmaceutical company developing novel multi-component ... present at the,Wachovia 2008 Healthcare Conference in Boston, ... Among the topics of the presentation will ... developments, including Phase III development,activities related to its ...
    ... 28 Campbell Alliance, the leading,management consulting firm ... that Nader Naeymi-Rad, Senior,Vice President of the firm,s ... Summit Europe. The event will be held on ... in London, England., Mr. Naeymi-Rad,s presentation, titled ...
    Cached Biology Technology:Kendle to Present at the Wachovia 2008 Healthcare Conference 2Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit 2
    ... The lyophilization stabilizer is designed ... process and for long-term storage. ... toxic ingredients. It is a ... pH 7.2, and is superior to ...
    ... coating stabilizer is designed for stabilizing ... and antibodies for immunoassay development. ... during the coating and drying process ... It can also works as a ...
    ... Clinical is Tecans open platform for clinical ... safety and performance in the clinical diagnostic ... by flexible barcode reading and sample traceability ... the system complies with the IVD-Directive* established ...
    ... the smallest thermal cyclers on the market, which ... 0.5ml (20 samples) or 0.2ml microtube (25 samples) ... and cooling rate of 3.6C/sec and 2.0C/sec respectively ... Fast track programming with new quick dial facility ...
    Biology Products: